KMID : 0624620180510080394
|
|
BMB Reports 2018 Volume.51 No. 8 p.394 ~ p.399
|
|
Hindsiipropane B alleviates HIV-1 Tat-induced inflammatory responses by suppressing HDAC6-NADPH oxidase-ROS axis in astrocytes
|
|
Jo Hyun-Dong
Jang Ha-Young Youn Gi-Soo Kim Dong-Gyu Lee Chae-Yeon Jang Jae-Hee Choi Soo-Young Jun Jong-Gab Park Jin-Seu
|
|
Abstract
|
|
|
Human immunodeficiency virus-1 (HIV-1) transactivator of transcription (Tat) is an important viral factor in neuroinflammation. Hindsiipropane B, present in Celastrus hindsii, possesses various biological mechanisms including anti-inflammatory activity. In this report, we explored the regulatory activity of hindsiipropane B on HIV-1 Tat-mediated chemokine production and its mode of action in astrocytes. Hindsiipropane B significantly alleviated HIV-1 Tat-mediated production of inflammatory chemokines, CCL2, CXCL8, and CXCL10. Hindsiipropane B inhibited expression of HDAC6, which is important regulator in HIV-1 Tat-mediated chemokine production. Hindsiipropane B diminished HIV-1 Tat-mediated reactive oxygen species (ROS) generation and NADPH oxidase activation/expression. Furthermore, hindsiipropane B inhibited HIV-1 Tat-mediated signaling cascades including MAPK, NF-¥êB, and AP-1. These data suggest that hindsiipropane B exerts its inhibitory effects on HIV-1 Tat-mediated chemokine production via down-regulating the HDAC6-NADPH oxidase-MAPK-NF-¥êB/AP-1 signaling axis, and could serve as a therapeutic lead compound against HIV-1 Tat-associated neuroinflammation.
|
|
KEYWORD
|
|
Chemokines, HDAC6, HIV-1 Tat, Inflammation, NADPH oxidase
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|